Contributions of PET and MRI imaging in the evaluation of CNS drugs in human neurodegenerative diseases - Aix-Marseille Université Access content directly
Journal Articles Thérapie Year : 2021

Contributions of PET and MRI imaging in the evaluation of CNS drugs in human neurodegenerative diseases

Abstract

This manuscript reviews the contributions of the neuroimaging methods including PET, conventional and advanced MRI methods to monitor the effect of new disease modifying drugs in neurodegenerative diseases. It now seems obvious that in many pathologies these two techniques are more and more complementary.

Domains

Imaging
Fichier principal
Vignette du fichier
S0040595720302250.pdf (180.24 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03500764 , version 1 (24-04-2023)

Licence

Attribution - NonCommercial

Identifiers

Cite

Pierre Payoux, Jean-Philippe Ranjeva. Contributions of PET and MRI imaging in the evaluation of CNS drugs in human neurodegenerative diseases. Thérapie, 2021, 76 (2), pp.121-126. ⟨10.1016/j.therap.2020.12.008⟩. ⟨hal-03500764⟩
33 View
22 Download

Altmetric

Share

Gmail Facebook X LinkedIn More